510(k) K162969

LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set by DiaSorin, Inc. — Product Code LFZ

K162969 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set". The FDA issued a decision of Substantially Equivalent on January 6, 2017. The device falls under product code LFZ (Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 6, 2017
Date Received
October 24, 2016
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Device Class
Class II
Regulation Number
866.3175
Review Panel
MI
Submission Type